Correlation Between Janux Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Janux Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Janux Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Janux Therapeutics and Aerovate Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Janux and Aerovate is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Janux Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Janux Therapeutics is expected to under-perform the Aerovate Therapeutics. In addition to that, Janux Therapeutics is 2.16 times more volatile than Aerovate Therapeutics. It trades about -0.37 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 253.00 in Aerovate Therapeutics on October 20, 2024 and sell it today you would earn a total of 5.00 from holding Aerovate Therapeutics or generate 1.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Janux Therapeutics vs. Aerovate Therapeutics
Performance |
| Timeline |
| Janux Therapeutics |
| Aerovate Therapeutics |
Janux Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Janux Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Janux Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute | Janux Therapeutics vs. Keros Therapeutics |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |